Tag: CLFS

XIFIN Highlights Flaws in CMS 2018 Draft PAMA Pricing

| September 25, 2017 | 0 Comments

Rate Setting Not Market-based and Circumvents Legislative Intent SAN DIEGO, Calif., Sept. 25, 2017 /PRNewswire/ — XIFIN, Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, has conducted an initial review of the draft laboratory rates published on Sept. 22 by the Centers for Medicare and Medicaid Services for 2018 clinical laboratory tests under the Protecting Access […]

Continue Reading